Journal of Analytical Chemistry

, Volume 69, Issue 7, pp 674–680 | Cite as

Development and validation of RP-HPLC, HPTLC and UV-visible spectrophotometric methods for simultaneous estimation of alprazolam and propranolol hydrochloride in their combined dosage form

  • D. C. Patel
  • N. R. Patel
  • O. D. Sherikar
  • P. J. Mehta
Articles

Abstract

Three accurate, sensitive and reproducible methods are described for the quantitative determination of alprazolam (ALP) and propranolol hydrochloride (PNL) in their combined dosage form. The first method involves an RP-HPLC separation on the C18 column using acetonitrile-25 mM ammonium acetate buffer and 0.2% triethylamine (pH of buffer adjusted to 4 with glacial acetic acid) in the ratio of 35: 65 (v/v) as mobile phase. Symmetrical peaks with good separation, ALP at 9.3 min and PNL at 3.5 min, were achieved. Quantification was done with photo diode array detection at 255 nm over the concentration ranges of 0.5–50 and 10–250 μg/mL for ALP and PNL, respectively. The second method is based on the separation of drugs by HPTLC using chloroform-methanol-ammonia 7: 0.8: 0.1 (v/v/v) as mobile phase. Quantification was achieved using UV detection at 248 nm over the concentration range of 100–600 ng/spot and 5–30 μg/spot for ALP and PNL, respectively. The third method involves dual wavelength UV-visible spectrophotometric method. It is based on the determination of PNL at 319.4 nm using its absorptivity value and ALP at 258.2 nm after deduction of absorbance due to PNL. Quantification was achieved over the concentration range of 1–40 and 80–200 μg/mL for ALP and PNL, respectively. All methods were validated according to ICH guidelines and successively applied to marketed pharmaceutical formulation, and the results of all three methods were compared statistically as well. No interference from the tablet excipients was found.

Keywords

RP-HPLC HPTLC UV-visible spectrophotometry alprazolam propranolol hydrochloride 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Merck Index, Merck Research Labs, 2001, 13th ed.Google Scholar
  2. 2.
    Kumar, K., Mohanakrishna, A., Sudheer, M., Sai Rajesh, K., and Ramalingam, P., Int. J. Chem. Tech. Res., 2011, vol. 3, no.1, p. 161.Google Scholar
  3. 3.
    Patel, R.B., Patel, M.R., Shankar, M.B., and Bhatt, K.K., Anal. Letters., 2009, vol. 42, nos. 10–12, p. 1588.CrossRefGoogle Scholar
  4. 4.
    Patel, R.B., Patel, M.R., Shankar, M.B., and Bhatt, K.K., J. AOAC. Int., 2009, vol. 92, no. 4, p. 1082.Google Scholar
  5. 5.
    Venkateswarlu, K., Venisetty, R.K., Yellu, N.R., and Keshetty, S., J. Chrom. Sci., 2007, vol. 45, no. 8, p. 537.CrossRefGoogle Scholar
  6. 6.
    Patel, R.B., Patel, M.R., Shankar, M.B., and Bhatt, K.K., Eur. J. Anal. Chem., 2009, vol. 4, no. 1, p. 76.Google Scholar
  7. 7.
    Kumar, A., Goyal, A., and Chomwal, R., Ind. Pharmacist, 2010, vol. 8, no. 10, p. 47.Google Scholar
  8. 8.
    Sajjan, A.G., Seetharamappa, J., and Masti, S.P., Ind. J. Pharm. Sci., 2002, vol. 64, no. 1, p. 68.Google Scholar
  9. 9.
    Rekhi, G.S., Jambhekar, S.S., Souney, P.F., and Williams, D.A., J. Pharm. Biomed. Anal., 1995, vol. 13, no. 12, p. 1499.CrossRefGoogle Scholar
  10. 10.
    Ei-Yazigi, A., and Martin, C.R., Clin. Chem., 1, vol. 31, no. 7, p. 1196.Google Scholar
  11. 11.
    Antonio, J.B., Pilar, M., and Eduardo, L.M., J. Chromatogr., B, 2000, vol. 738, no. 2, p. 225.CrossRefGoogle Scholar
  12. 12.
    Krzek, J. and Kwiecien, A., J. Planar Chromatogr., 2005, vol. 104, no. 18, p. 308.CrossRefGoogle Scholar
  13. 13.
    Bhavar, G., and Chatpalliwar, V.A., Ind. J. Pharm. Sci., 2008, vol. 70, no. 3, p. 395.CrossRefGoogle Scholar
  14. 14.
    Ei-Emam, A.A., Belal, F.F., Moustafa, M.A., and EiAshry, S.M., Il Farmaco, 2003, vol. 58, no. 11, p. 1179.CrossRefGoogle Scholar
  15. 15.
    Babu, G.G., Jaldappa, S., and Mahaveer, B., Anal. Sci., 2002, vol. 18, no. 6, p. 671.CrossRefGoogle Scholar
  16. 16.
    Yamaguchi, T., Murase, H., Mori, I., and Fujita, Y., Bunseki Kagaku, 2001, vol. 50, no. 8, p. 563.CrossRefGoogle Scholar
  17. 17.
    Madralian, T., Afkhami, A., and Mohammadnejad, M., Talanta, 2009, vol. 78, no. 3, p. 1051.CrossRefGoogle Scholar
  18. 18.
    Tulja, R.G., Gowri, S.D., Kadgapathi, P., and Satyanarayana, B., J. Pharm. Res., 2011, vol. 4, no. 2, p. 358.Google Scholar
  19. 19.
    ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures. Geneva: Int. Conf. on Harmonization, 2005.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2014

Authors and Affiliations

  • D. C. Patel
    • 1
  • N. R. Patel
    • 1
  • O. D. Sherikar
    • 1
  • P. J. Mehta
    • 1
  1. 1.Department of Pharmaceutical Analysis, Institute of PharmacyNirma University Sarkhej-Gandhinagar HighwayAhmedabad, GujaratIndia

Personalised recommendations